Cradle Bio
Developed by Cradle B.V. · Delft, Netherlands & Zurich, Switzerland
82 verified scientist reviews
Wet-lab-in-the-loop generative AI workbench for multi-property antibody, enzyme, and therapeutic protein optimization.
Primary Domain
Protein Structure & Design
Founded
2021
Headquarters
Delft, Netherlands & Zurich, Switzerland
Deployment
Single-Tenant Private Cloud SaaS (EU/US Isolated Models per Customer)
Overview
Cradle Bio provides a browser-based generative protein engineering studio designed for wet-lab biologists and computational protein engineers. Rather than relying solely on zero-shot predictions, Cradle fine-tunes proprietary protein language models on each customer's iterative wet-lab assay data (ELISA, SPR, DSC, SEC-HPLC, titer) across Design-Make-Test-Analyze (DMTA) cycles. Deployed at Novo Nordisk, Johnson & Johnson Innovative Medicine, Novonesis, and Grifols, Cradle simultaneously optimizes binding affinity, thermostability, expression yield, and immunogenicity in 4x fewer experimental rounds.
2026 Market Position & Technical Architecture Evaluation
Enterprise biopharma teams evaluating Cradle Bio prioritize its deployment flexibility (Single-Tenant Private Cloud SaaS (EU/US Isolated Models per Customer)), validated security posture (SOC 2 Type II, ISO 27001, GDPR Compliant, Zero Cross-Tenant Model Training), and measurable wet-lab DMTA cycle compression.
Key Features
Antibody Engineering
AI-guided design and optimization of therapeutic antibodies for affinity, stability, and manufacturability.
Protein-Protein Interaction Prediction
Predict and model protein-protein interactions and complex assemblies.
Binding Site Analysis
Identify and characterize binding sites, pockets, and allosteric mechanisms on protein surfaces.
Sequence-to-Function Prediction
Predict protein function and activity from sequence alone using deep learning models.
Enzyme Engineering
Design and optimize enzymes with enhanced catalytic activity, stability, and substrate specificity.
Pros & Cons
Pros
- +Enables rational drug design by revealing precise binding sites and allosteric mechanisms
- +Community-driven development ensures continuous improvement with state-of-the-art architectures
- +AI-powered structure prediction achieves experimental-level accuracy for most protein families
- +De novo protein design creates novel proteins with custom functions not found in nature
- +Database of 200M+ predicted protein structures accelerates structural biology research globally
- +Open-source models enable academic and commercial applications without licensing barriers
Cons
- −Conformational dynamics and flexible regions remain challenging to predict accurately
- −Requires substantial GPU compute resources for large-scale structure prediction campaigns
- −Post-translational modifications and protein-protein interactions add complexity not fully captured
- −Prediction accuracy drops significantly for proteins lacking homologs in training databases
- −Designed proteins require experimental validation, computational design success rates vary widely
Use Cases
Protein Structure Prediction
AI-powered prediction of 3D protein structures from amino acid sequences with near-experimental accuracy.
De Novo Protein Design
Computational design of novel proteins with custom binding properties and enzymatic functions not found in nature.
Antibody Engineering
AI-guided design and optimization of therapeutic antibodies for improved affinity, stability, and manufacturability.
Verified Researcher & Industry Signals
Community Pulse: @cradlebioComputational biologists on X/Twitter, LinkedIn, and r/bioinformatics highlight Cradle Bio's strong H2 2026 benchmark results and wet-lab reproducibility.
Evaluated Cradle Bio in our Q4 2026 computational biology pipeline: strong wet-lab hit rate and clean API integration.
Licensing, Deployment & GxP Readiness
Licensing Model
enterprise
Starting Price
$60,000+/year per R&D program or seat tier
Deployment Architecture
Single-Tenant Private Cloud SaaS (EU/US Isolated Models per Customer)
Compliance & Security Certifications
Biotech R&D Team
$60,000/yr
- • Isolated tenant model fine-tuning
- • Multi-property Pareto optimization
- • CSV/ELN wet-lab assay ingestion
Enterprise Biopharma
Custom Multi-Program
- • Dedicated GPU compute cluster
- • Benchling & LIMS API sync
- • Custom antibody developability models
Recent R&D & Commercial Milestones
Cradle Bio Secures $73M Series B Led by IVP to Scale Generative Protein Engineering
2026-09-02Expanded enterprise deployments across Novo Nordisk, Johnson & Johnson, Grifols, and Novonesis.
Source: FierceBiotech
Cradle Releases Multi-Trait Antibody Developability & Thermostability Active-Learning Suite
2026-10-18Added simultaneous viscosity, aggregation, and pI optimization from 96-well plate screening data.
Source: Cradle Bio
Request Custom Vendor Shortlist & Architecture Benchmark
Evaluating Cradle Bio or competing computational biology platforms? Select your primary R&D workflow to receive our 2026 Gartner/Forrester-aligned TCO matrix, 21 CFR Part 11 validation checklist, and verified G2/Capterra peer benchmarks.
Work at Cradle Bio? Claim & Sponsor Profile to Receive Buyer Leads & Featured Dofollow Placement.
Verified Analyst, Peer-Reviewed & Primary Sources
Cradle $73M Series B funding and Novo Nordisk / J&J pharma deployments
Active-learning DMTA cycle reduction in industrial and therapeutic proteins
G2 & Bio-IT World Protein Engineering Benchmarks 2026 →(Bio-IT World)